GlassScriptPhysician profile
Ibn Ansari
NPI 1346777927
$4,017.34
in general payments reported to CMS, 2019-2025
17 companies · $1,517 in 2025
The $1,517 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.77 · 2021: $30.39 · 2022: $1,682 · 2023: $293 · 2024: $484 · 2025: $1,517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,629 · Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,628.87 |
| Food and Beverage | $664.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,604.37 | 2022-2023 | Dart-Fire, Hoffmann, Vitoss |
| Paragon 28, INC. | $1,288.74 | 2025 | Portfolio |
| Treace Medical Concepts, INC. | $523.53 | 2024-2025 | |
| Triad Life Sciences INC. | $169.48 | 2022 | |
| Smith+Nephew, INC. | $57.28 | 2024 | Grafix Pl, Stravix |
| Horizon Therapeutics Plc | $57.02 | 2021-2023 | Krystexxa |
| Organogenesis INC. | $55.61 | 2024-2025 | Affinity |
| Cashflow Solutions, LLC | $48.57 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Abbvie INC. | $45.26 | 2022-2023 | Dalvance |
| Glaxosmithkline, LLC. | $29.69 | 2025 | Bexsero |
| Kowa Pharmaceuticals America, INC. | $28.96 | 2022 | |
| Kerecis Limited | $23.19 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Fidia Pharma USA INC. | $22.20 | 2023 | Triluron, Hymovis |
| Nabriva Therapeutics, Plc | $19.79 | 2022 | |
| Heron Therapeutics, INC. | $17.35 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $14.53 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medela LLC | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ibn Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.